Key result
Central extracellular mtDNA triggers hypertension via neural TGFβ signaling, reversible by receptor blockade.
Answers are grounded in this paper and cite their sources.
Demonstrates that extracellular mitochondrial DNA drives hypertension via central TGFβ signaling in obese mice, indicating a neural inflammatory mechanism.
Hypothalamic inflammation was recently found to mediate obesity-related hypertension, but the responsible upstream mediators remain unexplored. In this study, we show that dietary obesity is associated with extracellular release of mitochondrial DNA (mtDNA) into the cerebrospinal fluid and that central delivery of mtDNA mimics transforming growth factor-β (TGFβ) excess to activate downstream signaling pathways. Physiological study reveals that central administration of mtDNA or TGFβ is sufficient to cause hypertension in mice. Knockout of the TGFβ receptor in proopiomelanocortin neurons counteracts the hypertensive effect of not only TGFβ but also mtDNA excess, while the hypertensive action of central mtDNA can be blocked pharmacologically by a TGFβ receptor antagonist or genetically by TGFβ receptor knockout. Finally, we confirm that obesity-induced hypertension can be reversed through central treatment with TGFβ receptor antagonist. In conclusion, circulating mtDNA in the brain employs neural TGFβ pathway to mediate a central inflammatory mechanism of obesity-related hypertension.
No takes yet. Share an insight, caveat, or question.
Alé et al. (2016) studied Obesity-related hypertension. Central administration of mtDNA, TGFβ, or TGFβ receptor antagonist was evaluated on Blood pressure / hypertension. Central administration of extracellular mtDNA causes hypertension in mice via the neural TGFβ pathway, which is reversible by central TGFβ receptor antagonism.
Synapse has enriched 10 related papers. Consider them for comparative context: